{"transactions":[{"id":2107431,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-11-22T21:34:37.000Z","date":"2022-11-21","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning November 19, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning November 19, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001209191-22-058391","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122058391/doc4.xml","form_type":"4"}},{"id":2107430,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-11-22T21:34:37.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":1847,"price":15.07,"value":27834.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.99 to $15.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":61234,"source":{"system":"sec-edgar","filing":"0001209191-22-058391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122058391/doc4.xml","form_type":"4"}},{"id":2107429,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-11-22T21:34:37.000Z","date":"2022-11-19","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":63081,"source":{"system":"sec-edgar","filing":"0001209191-22-058391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122058391/doc4.xml","form_type":"4"}},{"id":2135806,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-10-19T01:22:50.000Z","date":"2022-10-15","kind":"exercise","acquired":false,"shares":2969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2969},"source":{"system":"sec-edgar","filing":"0001209191-22-054027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122054027/doc4.xml","form_type":"4"}},{"id":2135805,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-10-19T01:22:50.000Z","date":"2022-10-15","kind":"sale","acquired":false,"shares":1326,"price":15.81,"value":20964.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":56831,"source":{"system":"sec-edgar","filing":"0001209191-22-054027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122054027/doc4.xml","form_type":"4"}},{"id":2135804,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-10-19T01:22:50.000Z","date":"2022-10-15","kind":"exercise","acquired":true,"shares":2969,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":58157,"source":{"system":"sec-edgar","filing":"0001209191-22-054027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122054027/doc4.xml","form_type":"4"}},{"id":2284987,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-05-04T00:55:20.000Z","date":"2022-04-29","kind":"exercise","acquired":false,"shares":9616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."}],"balance_after":9616,"derivative":{"underlying":"Common Stock","underlying_shares":9616},"source":{"system":"sec-edgar","filing":"0001209191-22-026940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026940/doc4.xml","form_type":"4"}},{"id":2284986,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-05-04T00:55:20.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":2865,"price":18.1818,"value":52090.857,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.385, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":55188,"source":{"system":"sec-edgar","filing":"0001209191-22-026940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026940/doc4.xml","form_type":"4"}},{"id":2284985,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-05-04T00:55:20.000Z","date":"2022-04-29","kind":"exercise","acquired":true,"shares":9616,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":58053,"source":{"system":"sec-edgar","filing":"0001209191-22-026940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026940/doc4.xml","form_type":"4"}},{"id":2301756,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-04-07T22:42:10.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":144695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":144695,"derivative":{"underlying":"Common Stock","underlying_shares":144695},"source":{"system":"sec-edgar","filing":"0001209191-22-023739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023739/doc4.xml","form_type":"4"}},{"id":2301755,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-04-07T22:42:10.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":36174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":36174,"derivative":{"underlying":"Common Stock","underlying_shares":36174},"source":{"system":"sec-edgar","filing":"0001209191-22-023739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023739/doc4.xml","form_type":"4"}},{"id":2301754,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-07T22:42:10.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":124138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 5, 2023. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":124138,"derivative":{"exercise_price":25.75,"expiration_date":"2032-04-05","underlying":"Common Stock","underlying_shares":124138},"source":{"system":"sec-edgar","filing":"0001209191-22-023739","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023739/doc4.xml","form_type":"4"}},{"id":2372962,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T22:41:56.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":4919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":14758,"derivative":{"underlying":"Common Stock","underlying_shares":4919},"source":{"system":"sec-edgar","filing":"0001209191-22-013275","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013275/doc4.xml","form_type":"4"}},{"id":2372961,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-02-25T22:41:56.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":1501,"price":23.8,"value":35723.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":48437,"source":{"system":"sec-edgar","filing":"0001209191-22-013275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013275/doc4.xml","form_type":"4"}},{"id":2372960,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-02-25T22:41:56.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":4919,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49938,"source":{"system":"sec-edgar","filing":"0001209191-22-013275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013275/doc4.xml","form_type":"4"}},{"id":2439234,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-01-10T23:23:59.000Z","date":"2022-01-06","kind":"exercise","acquired":false,"shares":5444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":10889,"derivative":{"underlying":"Common Stock","underlying_shares":5444},"source":{"system":"sec-edgar","filing":"0001209191-22-002749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002749/doc4.xml","form_type":"4"}},{"id":2439233,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-01-10T23:23:59.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":1937,"price":23.05,"value":44647.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":45019,"source":{"system":"sec-edgar","filing":"0001209191-22-002749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002749/doc4.xml","form_type":"4"}},{"id":2439232,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-01-10T23:23:59.000Z","date":"2022-01-06","kind":"exercise","acquired":true,"shares":5444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":46956,"source":{"system":"sec-edgar","filing":"0001209191-22-002749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002749/doc4.xml","form_type":"4"}},{"id":2499164,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2021-11-23T23:00:24.000Z","date":"2021-11-19","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 11/19/2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 11/19/2019."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001209191-21-066570","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121066570/doc4.xml","form_type":"4"}},{"id":2499163,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-11-23T23:00:24.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":2803,"price":19.01,"value":53285.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":41512,"source":{"system":"sec-edgar","filing":"0001209191-21-066570","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121066570/doc4.xml","form_type":"4"}},{"id":2499162,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-11-23T23:00:24.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":44315,"source":{"system":"sec-edgar","filing":"0001209191-21-066570","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121066570/doc4.xml","form_type":"4"}},{"id":2539767,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2021-10-19T21:31:19.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":2969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":2969,"derivative":{"underlying":"Common Stock","underlying_shares":2969},"source":{"system":"sec-edgar","filing":"0001209191-21-060958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121060958/doc4.xml","form_type":"4"}},{"id":2539766,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-10-19T21:31:19.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":1338,"price":17.41,"value":23294.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":38065,"source":{"system":"sec-edgar","filing":"0001209191-21-060958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121060958/doc4.xml","form_type":"4"}},{"id":2539765,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-10-19T21:31:19.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":2969,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":39403,"source":{"system":"sec-edgar","filing":"0001209191-21-060958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121060958/doc4.xml","form_type":"4"}},{"id":2734870,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2021-04-30T22:53:12.000Z","date":"2021-04-29","kind":"exercise","acquired":false,"shares":9615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."}],"balance_after":19232,"derivative":{"underlying":"Common Stock","underlying_shares":9615},"source":{"system":"sec-edgar","filing":"0001209191-21-029357","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121029357/doc4.xml","form_type":"4"}},{"id":2734869,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-04-30T22:53:12.000Z","date":"2021-04-30","kind":"sale","acquired":false,"shares":4230,"price":20.33,"value":85995.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":36434,"source":{"system":"sec-edgar","filing":"0001209191-21-029357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121029357/doc4.xml","form_type":"4"}},{"id":2734868,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-04-30T22:53:12.000Z","date":"2021-04-29","kind":"exercise","acquired":true,"shares":9615,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."}],"balance_after":40664,"source":{"system":"sec-edgar","filing":"0001209191-21-029357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121029357/doc4.xml","form_type":"4"}},{"id":2833468,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2021-02-26T02:52:56.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":19677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":19677,"derivative":{"underlying":"Common Stock","underlying_shares":19677},"source":{"system":"sec-edgar","filing":"0001209191-21-014561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121014561/doc4.xml","form_type":"4"}},{"id":2833467,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-26T02:52:56.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":72463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2022. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":72463,"derivative":{"exercise_price":49.74,"expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":72463},"source":{"system":"sec-edgar","filing":"0001209191-21-014561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121014561/doc4.xml","form_type":"4"}},{"id":2875053,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-09T02:00:22.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":11875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On October 15, 2018, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the option as to 11,875 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On October 15, 2018, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the option as to 11,875 shares."}],"balance_after":11875,"derivative":{"exercise_price":21.28,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":11875},"source":{"system":"sec-edgar","filing":"0001209191-21-008660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008660/doc4.xml","form_type":"4"}},{"id":2875052,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-09T02:00:22.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":21875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On September 7, 2017, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the option as to 21,875 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 7, 2017, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the option as to 21,875 shares."}],"balance_after":21875,"derivative":{"exercise_price":35.8,"expiration_date":"2027-09-07","underlying":"Common Stock","underlying_shares":21875},"source":{"system":"sec-edgar","filing":"0001209191-21-008660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008660/doc4.xml","form_type":"4"}},{"id":2875051,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-09T02:00:22.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 3, 2017, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the option as to 15,625 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 3, 2017, the reporting person was granted an option to purchase shares of common stock based upon and subject to the achievement of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the option as to 15,625 shares."}],"balance_after":15625,"derivative":{"exercise_price":29.59,"expiration_date":"2027-08-03","underlying":"Common Stock","underlying_shares":15625},"source":{"system":"sec-edgar","filing":"0001209191-21-008660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008660/doc4.xml","form_type":"4"}},{"id":2875050,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-02-09T02:00:22.000Z","date":"2021-02-04","kind":"sale","acquired":false,"shares":8429,"price":50.61,"value":426591.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":31049,"source":{"system":"sec-edgar","filing":"0001209191-21-008660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008660/doc4.xml","form_type":"4"}},{"id":2875049,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-02-09T02:00:22.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":19231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2019, the reporting person was granted Restricted Stock Units (RSU's) that vest upon the Issuer's satisfaction of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the RSU's as to the number of shares reported in column 4 of row 1 above."}],"balance_after":39478,"source":{"system":"sec-edgar","filing":"0001209191-21-008660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008660/doc4.xml","form_type":"4"}},{"id":2907513,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-15T00:03:16.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option vested and became exercisable on November 19, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":89562,"derivative":{"exercise_price":18.12,"expiration_date":"2028-11-18","underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-21-003678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121003678/doc4.xml","form_type":"4"}},{"id":2907512,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-15T00:03:16.000Z","date":"2021-01-12","kind":"sale","acquired":false,"shares":700,"price":55.01,"value":38507.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20247,"source":{"system":"sec-edgar","filing":"0001209191-21-003678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121003678/doc4.xml","form_type":"4"}},{"id":2907511,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-15T00:03:16.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":700,"price":18.12,"value":12684.0,"ownership":{"direct":true},"balance_after":20947,"source":{"system":"sec-edgar","filing":"0001209191-21-003678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121003678/doc4.xml","form_type":"4"}},{"id":2912676,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-08","kind":"exercise","acquired":false,"shares":3488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the shares subject to the Stock Option vested and became exercisable on November 19, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":90262,"derivative":{"exercise_price":18.12,"expiration_date":"2028-11-18","underlying":"Common Stock","underlying_shares":3488},"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912675,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-08","kind":"exercise","acquired":false,"shares":12864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the shares subject to the Stock Option vested and became exercisable on October 15, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":22761,"derivative":{"exercise_price":21.28,"expiration_date":"2028-10-14","underlying":"Common Stock","underlying_shares":12864},"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912674,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-08","kind":"exercise","acquired":false,"shares":13381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the Stock Option vested and became exercisable on September 7, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":56250,"derivative":{"exercise_price":35.8,"expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":13381},"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912673,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-06","kind":"exercise","acquired":false,"shares":61619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the Stock Option vested and became exercisable on September 7, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":69631,"derivative":{"exercise_price":35.8,"expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":61619},"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912672,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-06","kind":"exercise","acquired":false,"shares":5444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":16333,"derivative":{"underlying":"Common Stock","underlying_shares":5444},"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912671,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":29733,"price":55.2192,"value":1641832.4736,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20247,"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912670,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-08","kind":"exercise","acquired":true,"shares":3488,"price":18.12,"value":63202.56,"ownership":{"direct":true},"balance_after":49980,"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912669,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-08","kind":"exercise","acquired":true,"shares":12864,"price":21.28,"value":273745.92,"ownership":{"direct":true},"balance_after":46492,"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912668,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-08","kind":"exercise","acquired":true,"shares":13381,"price":35.8,"value":479039.8,"ownership":{"direct":true},"balance_after":33628,"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912667,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":61619,"price":55.1159,"value":3396186.6421,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2020."}],"balance_after":20247,"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912666,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-07","kind":"exercise","acquired":true,"shares":61619,"price":35.8,"value":2205960.2,"ownership":{"direct":true},"balance_after":81866,"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912665,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":1725,"price":53.34,"value":92011.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":20247,"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2912664,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-09T00:28:46.000Z","date":"2021-01-06","kind":"exercise","acquired":true,"shares":5444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":21972,"source":{"system":"sec-edgar","filing":"0001209191-21-002831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002831/doc4.xml","form_type":"4"}},{"id":2971601,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2020-11-21T02:29:36.000Z","date":"2020-11-19","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 11/19/2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 11/19/2019."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001209191-20-059854","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120059854/doc4.xml","form_type":"4"}},{"id":2971600,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-11-21T02:29:36.000Z","date":"2020-11-20","kind":"sale","acquired":false,"shares":2728,"price":53.5,"value":145948.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":16528,"source":{"system":"sec-edgar","filing":"0001209191-20-059854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120059854/doc4.xml","form_type":"4"}},{"id":2971599,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-11-21T02:29:36.000Z","date":"2020-11-19","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":19256,"source":{"system":"sec-edgar","filing":"0001209191-20-059854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120059854/doc4.xml","form_type":"4"}},{"id":3004404,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2020-10-19T21:26:31.000Z","date":"2020-10-15","kind":"exercise","acquired":false,"shares":2969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":5938,"derivative":{"underlying":"Common Stock","underlying_shares":2969},"source":{"system":"sec-edgar","filing":"0001209191-20-055316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120055316/doc4.xml","form_type":"4"}},{"id":3004403,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-10-19T21:26:31.000Z","date":"2020-10-16","kind":"sale","acquired":false,"shares":1297,"price":42.56,"value":55200.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":13006,"source":{"system":"sec-edgar","filing":"0001209191-20-055316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120055316/doc4.xml","form_type":"4"}},{"id":3004402,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-10-19T21:26:31.000Z","date":"2020-10-15","kind":"exercise","acquired":true,"shares":2969,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":14303,"source":{"system":"sec-edgar","filing":"0001209191-20-055316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120055316/doc4.xml","form_type":"4"}},{"id":3104568,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-19","kind":"exercise","acquired":false,"shares":16452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the Stock Option vested and became exercisable on November 19, 2019. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":93750,"derivative":{"exercise_price":18.12,"expiration_date":"2028-11-18","underlying":"Common Stock","underlying_shares":16452},"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3104567,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-18","kind":"exercise","acquired":false,"shares":39798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the Stock Option vested and became exercisable on November 19, 2019. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":110202,"derivative":{"exercise_price":18.12,"expiration_date":"2028-11-18","underlying":"Common Stock","underlying_shares":39798},"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3104566,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-18","kind":"exercise","acquired":false,"shares":17494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the Stock Option vested and became exercisable on April 18, 2019. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":34112,"derivative":{"exercise_price":19.98,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":17494},"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3104565,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-18","kind":"exercise","acquired":false,"shares":8551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":19.65,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":8551},"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3104564,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-19","kind":"sale","acquired":false,"shares":16452,"price":50.1164,"value":824515.0128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"were sold in multiple transactions at prices ranging from $50.00 to $50.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11334,"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3104563,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-19","kind":"exercise","acquired":true,"shares":16452,"price":18.12,"value":298110.24,"ownership":{"direct":true},"balance_after":27786,"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3104562,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-18","kind":"sale","acquired":false,"shares":65843,"price":50.0088,"value":3292729.4184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.175, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":11334,"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3104561,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-18","kind":"exercise","acquired":true,"shares":39798,"price":18.12,"value":721139.76,"ownership":{"direct":true},"balance_after":77177,"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3104560,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-18","kind":"exercise","acquired":true,"shares":17494,"price":19.98,"value":349530.12,"ownership":{"direct":true},"balance_after":37379,"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3104559,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-06-19T22:55:31.000Z","date":"2020-06-18","kind":"exercise","acquired":true,"shares":8551,"price":19.65,"value":168027.15,"ownership":{"direct":true},"balance_after":19885,"source":{"system":"sec-edgar","filing":"0001209191-20-038065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038065/doc4.xml","form_type":"4"}},{"id":3165972,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2020-05-01T22:00:12.000Z","date":"2020-04-29","kind":"exercise","acquired":false,"shares":9615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."}],"balance_after":28847,"derivative":{"underlying":"Common Stock","underlying_shares":9615},"source":{"system":"sec-edgar","filing":"0001209191-20-026614","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120026614/doc4.xml","form_type":"4"}},{"id":3165971,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-05-01T22:00:12.000Z","date":"2020-04-30","kind":"sale","acquired":false,"shares":4308,"price":49.21,"value":211996.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":11334,"source":{"system":"sec-edgar","filing":"0001209191-20-026614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120026614/doc4.xml","form_type":"4"}},{"id":3165970,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-05-01T22:00:12.000Z","date":"2020-04-29","kind":"exercise","acquired":true,"shares":9615,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."}],"balance_after":15642,"source":{"system":"sec-edgar","filing":"0001209191-20-026614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120026614/doc4.xml","form_type":"4"}},{"id":3170469,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-04-24T22:00:12.000Z","date":"2020-04-23","kind":"exercise","acquired":false,"shares":11875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on October 15, 2019. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":35625,"derivative":{"exercise_price":21.28,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":11875},"source":{"system":"sec-edgar","filing":"0001209191-20-025677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025677/doc4.xml","form_type":"4"}},{"id":3170468,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-04-24T22:00:12.000Z","date":"2020-04-23","kind":"exercise","acquired":false,"shares":7074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable."}],"balance_after":8551,"derivative":{"exercise_price":19.65,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":7074},"source":{"system":"sec-edgar","filing":"0001209191-20-025677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025677/doc4.xml","form_type":"4"}},{"id":3170467,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-04-24T22:00:12.000Z","date":"2020-04-23","kind":"sale","acquired":false,"shares":18949,"price":50.0675,"value":948729.0575,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6027,"source":{"system":"sec-edgar","filing":"0001209191-20-025677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025677/doc4.xml","form_type":"4"}},{"id":3170466,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-04-24T22:00:12.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":11875,"price":21.28,"value":252700.0,"ownership":{"direct":true},"balance_after":24976,"source":{"system":"sec-edgar","filing":"0001209191-20-025677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025677/doc4.xml","form_type":"4"}},{"id":3170465,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-04-24T22:00:12.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":7074,"price":19.65,"value":139004.1,"ownership":{"direct":true},"balance_after":13101,"source":{"system":"sec-edgar","filing":"0001209191-20-025677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025677/doc4.xml","form_type":"4"}},{"id":3171959,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-04-22T22:30:46.000Z","date":"2020-04-22","kind":"exercise","acquired":false,"shares":19644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the Stock Option vested and became exercisable on April 18, 2019. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":51606,"derivative":{"exercise_price":19.98,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":19644},"source":{"system":"sec-edgar","filing":"0001209191-20-025379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025379/doc4.xml","form_type":"4"}},{"id":3171958,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-04-22T22:30:46.000Z","date":"2020-04-22","kind":"exercise","acquired":false,"shares":34375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":15625,"derivative":{"exercise_price":19.65,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":34375},"source":{"system":"sec-edgar","filing":"0001209191-20-025379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025379/doc4.xml","form_type":"4"}},{"id":3171957,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-04-22T22:30:46.000Z","date":"2020-04-20","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and exercisable."}],"balance_after":50000,"derivative":{"exercise_price":19.65,"expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-025379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025379/doc4.xml","form_type":"4"}},{"id":3171956,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-04-22T22:30:46.000Z","date":"2020-04-22","kind":"sale","acquired":false,"shares":54019,"price":50.0177,"value":2701906.1363,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6027,"source":{"system":"sec-edgar","filing":"0001209191-20-025379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025379/doc4.xml","form_type":"4"}},{"id":3171955,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-04-22T22:30:46.000Z","date":"2020-04-22","kind":"exercise","acquired":true,"shares":19644,"price":19.98,"value":392487.12,"ownership":{"direct":true},"balance_after":60046,"source":{"system":"sec-edgar","filing":"0001209191-20-025379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025379/doc4.xml","form_type":"4"}},{"id":3171954,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-04-22T22:30:46.000Z","date":"2020-04-22","kind":"exercise","acquired":true,"shares":34375,"price":19.65,"value":675468.75,"ownership":{"direct":true},"balance_after":40402,"source":{"system":"sec-edgar","filing":"0001209191-20-025379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025379/doc4.xml","form_type":"4"}},{"id":3171953,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-04-22T22:30:46.000Z","date":"2020-04-20","kind":"sale","acquired":false,"shares":100000,"price":50.1545,"value":5015450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":6027,"source":{"system":"sec-edgar","filing":"0001209191-20-025379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025379/doc4.xml","form_type":"4"}},{"id":3171952,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-04-22T22:30:46.000Z","date":"2020-04-20","kind":"exercise","acquired":true,"shares":100000,"price":19.65,"value":1965000.0,"ownership":{"direct":true},"balance_after":106027,"source":{"system":"sec-edgar","filing":"0001209191-20-025379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120025379/doc4.xml","form_type":"4"}},{"id":3315473,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2020-01-08T23:05:54.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":21777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":21777,"derivative":{"underlying":"Common Stock","underlying_shares":21777},"source":{"system":"sec-edgar","filing":"0001209191-20-002598","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120002598/doc4.xml","form_type":"4"}},{"id":3315472,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-01-08T23:05:54.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":79031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on January 6, 2021. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":79031,"derivative":{"exercise_price":42.81,"expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":79031},"source":{"system":"sec-edgar","filing":"0001209191-20-002598","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120002598/doc4.xml","form_type":"4"}},{"id":3363369,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2019-11-21T22:37:14.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning 11/19/2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning 11/19/2019."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001209191-19-057636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119057636/doc4.xml","form_type":"4"}},{"id":3363368,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2019-11-21T22:37:14.000Z","date":"2019-11-19","kind":"sale","acquired":false,"shares":2160,"price":46.41,"value":100245.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price, and includes 2,153 shares sold at $46.41 and 7 shares sold at $46.7644."}],"balance_after":6027,"source":{"system":"sec-edgar","filing":"0001209191-19-057636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119057636/doc4.xml","form_type":"4"}},{"id":3363367,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2019-11-21T22:37:14.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":8187,"source":{"system":"sec-edgar","filing":"0001209191-19-057636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119057636/doc4.xml","form_type":"4"}},{"id":3392374,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2019-10-17T22:24:37.000Z","date":"2019-10-15","kind":"exercise","acquired":false,"shares":2968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":8907,"derivative":{"underlying":"Common Stock","underlying_shares":2968},"source":{"system":"sec-edgar","filing":"0001209191-19-053492","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119053492/doc4.xml","form_type":"4"}},{"id":3392373,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2019-10-17T22:24:37.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":1031,"price":39.65,"value":40879.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":1937,"source":{"system":"sec-edgar","filing":"0001209191-19-053492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119053492/doc4.xml","form_type":"4"}},{"id":3392372,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2019-10-17T22:24:37.000Z","date":"2019-10-15","kind":"exercise","acquired":true,"shares":2968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":2968,"source":{"system":"sec-edgar","filing":"0001209191-19-053492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119053492/doc4.xml","form_type":"4"}},{"id":3544595,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2019-05-01T21:57:23.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":38462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."}],"balance_after":38462,"derivative":{"underlying":"Common Stock","underlying_shares":38462},"source":{"system":"sec-edgar","filing":"0001209191-19-026844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119026844/doc4.xml","form_type":"4"}},{"id":3544594,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-05-01T21:57:23.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":134953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 29, 2020. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":134953,"derivative":{"exercise_price":25.12,"expiration_date":"2029-04-29","underlying":"Common Stock","underlying_shares":134953},"source":{"system":"sec-edgar","filing":"0001209191-19-026844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119026844/doc4.xml","form_type":"4"}},{"id":3757529,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2018-11-20T21:40:40.000Z","date":"2018-11-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning November 19, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning November 19, 2019."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-059445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919118059445/doc4.xml","form_type":"4"}},{"id":3757528,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2018-11-20T21:40:40.000Z","date":"2018-11-19","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on November 19, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":150000,"derivative":{"exercise_price":18.12,"expiration_date":"2028-11-18","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-059445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919118059445/doc4.xml","form_type":"4"}},{"id":3784308,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP"}}],"security":"Restricted Stock Units","published_at":"2018-10-24T20:24:29.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":11875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning October 15, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning October 15, 2019."}],"balance_after":11875,"derivative":{"underlying":"Common Stock","underlying_shares":11875},"source":{"system":"sec-edgar","filing":"0000899243-18-027360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000089924318027360/doc4.xml","form_type":"4"}},{"id":3784307,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-24T20:24:29.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on October 15, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":47500,"derivative":{"exercise_price":21.28,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0000899243-18-027360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000089924318027360/doc4.xml","form_type":"4"}},{"id":3959496,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP"}}],"security":"Stock Option (right to buy)","published_at":"2018-04-20T22:34:44.000Z","date":"2018-04-18","kind":"grant","acquired":true,"shares":71250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on April 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":71250,"derivative":{"exercise_price":19.98,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":71250},"source":{"system":"sec-edgar","filing":"0001415889-18-000656","document":"form4-04202018_030430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000656/form4-04202018_030430.xml","form_type":"4"}},{"id":4213863,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP"}}],"security":"Stock Option (right to buy)","published_at":"2017-09-08T22:13:39.000Z","date":"2017-09-07","kind":"grant","acquired":true,"shares":131250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on September 7, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":131250,"derivative":{"exercise_price":35.8,"expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":131250},"source":{"system":"sec-edgar","filing":"0001415889-17-001470","document":"form4-09082017_030927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001470/form4-09082017_030927.xml","form_type":"4"}},{"id":4391105,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":122151,"kind":"person","name":"Stankovic Srdjan R.","position":1,"cik":"0001432545","reported_name":"Stankovic Srdjan R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-11T01:38:01.000Z","date":"2017-03-08","kind":"grant","acquired":true,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on March 8, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":93750,"derivative":{"exercise_price":36.54,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001415889-17-000408","document":"form4-03102017_050352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000408/form4-03102017_050352.xml","form_type":"4"}}]}